Stillbirth (death after 24 weeks inutero)
1 finding from 1 review
Preterm birth less than 34 weeks' gestation
It is very uncertain whether cervical cerclage in combination with antibiotics and tocolytics changes preterm birth < 34 completed weeks of pregnancy compared with cervical cerclage alone (very low certainty).
1 finding from 1 review
All perinatal losses · preventing preterm birth in women with singleton pregnancy
Cerclage showed no clear difference in all perinatal losses compared with no cerclage (moderate certainty).
1 finding from 1 review
Serious neonatal morbidity · preventing preterm birth in women with singleton pregnancy
Cerclage showed no clear difference in serious neonatal morbidity compared with no cerclage (low certainty).
1 finding from 1 review
Baby discharged home healthy · preventing preterm birth in women with singleton pregnancy
Cerclage showed no clear difference in baby discharged home healthy compared with no cerclage (moderate certainty).
1 finding from 1 review
Stillbirth · preventing preterm birth in women with singleton pregnancy
Cerclage showed no clear difference in stillbirths compared with no cerclage (low certainty).
1 finding from 1 review
Death of the baby before discharge: neonatal death · preventing preterm birth in women with singleton pregnancy
Cerclage showed no clear difference in neonatal deaths before discharge compared with no cerclage (low certainty).
1 finding from 1 review
Preterm birth less than 34 weeks' gestation · preventing preterm birth in women with singleton pregnancy
Cerclage leads to lower preterm birth before 34 completed weeks compared with no cerclage (high certainty).
1 finding from 1 review
Intervention not reported
Weight: Gain‐more than or equal to 7% from baseline · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
The intervention showed no clear difference in weight: Gain‐more than or equal to 7% from baseline (moderate certainty).
1 finding from 1 review
Intervention not reported
Weight: BMI not improved · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
1 finding from 1 review
Intervention not reported
Physiological measure: Metabolic syndrome · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
1 finding from 1 review
Intervention not reported
Global state: Average change (CGI‐I, high=good) · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
1 finding from 1 review
Intervention not reported
Mental state: Average change (PANSS, high decline=good) · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
1 finding from 1 review
Intervention not reported
Adverse events: Any event · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
The intervention showed no clear difference in adverse events: Any event (moderate certainty).
1 finding from 1 review
Intervention not reported
Satisfaction with care: Loss to · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
It is very uncertain whether the intervention changes satisfaction with care: Loss to (very low certainty).
1 finding from 1 review